+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Methamphetamine use and heart failure: Prevalence, risk factors, and predictors



Methamphetamine use and heart failure: Prevalence, risk factors, and predictors



American Journal of Emergency Medicine 36(8): 1423-1428



To compare methamphetamine users who develop heart failure to those who do not and determine predictors. Patients presenting over a two-year period testing positive for methamphetamine on their toxicology screen were included. Demographics, vital signs, echocardiography and labs were compared between patients with normal versus abnormal B-type natriuretic peptide (BNP). 4407 were positive for methamphetamine, 714 were screened for heart failure, and 450 (63%) had abnormal BNP. The prevalence of abnormal BNP in methamphetamine-positive patients was 10.2% versus 6.7% for those who were negative or not tested. For methamphetamine-positive patients, there was a tendency for higher age and male gender with abnormal BNP. A higher proportion of Whites and former smokers had abnormal BNP and higher heart and respiratory rates. Echocardiography revealed disparate proportions for normal left ventricular ejection fraction (LVEF) and severe dysfunction (LVEF <30%), LV diastolic function, biventricular dimensions, and pulmonary arterial pressures between subgroups. For methamphetamine-positive patients with abnormal BNP, creatinine was significantly higher, but not Troponin I. Logistic regression analysis revealed predictors of abnormal BNP and LVEF <30% in methamphetamine-positive patients, which included age, race, smoking history, elevated creatinine, and respiratory rate. Methamphetamine-positive patients have a significantly higher prevalence of heart failure than the general emergency department population who are methamphetamine-negative or not tested. The methamphetamine-positive subgroup who develop heart failure tend to be male, older, White, former smokers, and have higher creatinine, heart and respiratory rates. This subgroup also has greater biventricular dysfunction, dimensions, and higher pulmonary arterial pressures.

(PDF emailed within 0-6 h: $19.90)

Accession: 065313443

Download citation: RISBibTeXText

PMID: 29307766

DOI: 10.1016/j.ajem.2018.01.001


Related references

Risk factors associated with methamphetamine use and heart failure among native Hawaiians and other Pacific Island peoples. Vascular Health and Risk Management 5(1): 45-52, 2009

Risk factors as predictors of sexual activity in heart failure. Dimensions of Critical Care Nursing 28(3): 123-9; Quiz 130-1, 2009

Angiotensin system polymorphisms and traditional risk factors as predictors of heart failure prognosis. Clinical Pharmacology & Therapeutics 77(2): P63-P63, 2005

Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors. Diabetes Care 24(9): 1614-1619, 2001

Consideration of beta-1 adrenergic receptor polymorphisms along with traditional risk factors as predictors of prognosis in patients with heart failure. Clinical Pharmacology & Therapeutics 75(2): P55, February, 2004

Predictors of incident heart failure in patients after an acute coronary syndrome: The LIPID heart failure risk-prediction model. International Journal of Cardiology 248: 361-368, 2017

Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis in risk factors. Kidney International 47(3): 884-890, 1995

Congestive heart failure in dialysis patients Prevalence incidence, risk factors and prognosis. Clinical Research 42(2): 262A, 1994

Prevalence and risk factors of heart failure in the USA: NHANES 2013 - 2014 epidemiological follow-up study. Journal of Community Hospital Internal Medicine Perspectives 7(1): 15-20, 2017

Asymptomatic coronary artery disease in chagasic patients with heart failure: prevalence and risk factors. Arquivos Brasileiros de Cardiologia 97(5): 408-412, 2012

High incidence of elevated B-type natriuretic peptide levels and risk factors for heart failure in an unselected at-risk population (stage A): implications for heart failure screening programs. Congestive Heart Failure 9(3): 127-132, 2003

Prevalence, incidence and risk factors of chronic heart failure in the type 2 diabetic population: systematic review. Current Diabetes Reviews 5(3): 171-184, 2009

Prevalence and Risk Factors of Heart Failure with Preserved Ejection Fraction: A Population-Based Study in Northeast China. International Journal of Environmental Research and Public Health 13(8), 2017

Methamphetamine-Associated Congestive Heart Failure: Increasing Prevalence and Relationship of Clinical Outcomes to Continued Use or Abstinence. Cardiovascular Toxicology 16(4): 381-389, 2017

Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study. European Heart Journal 25(18): 1614-1619, 2004